2009 Clinical Trials Consumption Oil 
The Cannigma
MAY 17, 2022
Another study from 2009 found that cannabis users had more “rare-creative” responses than a control group, even if they didn’t rate themselves as more creative in a self-report. A side effect of cannabis consumption is increased blood flow, particularly in the brain. So if cannabis does improve creativity for some people, how?
Cannabis Law Report
JUNE 4, 2021
He practiced as a British Physiotherapist for over fifteen years, running clinics that specialized in integrative pain management and injury rehabilitation, treating over 40,000 patients. His first-hand experience with therapeutic hemp oil products as nutritional supplements led him to Medical Marijuana Inc. David Marelius, PhD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JANUARY 13, 2023
Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. 3 A 2009 study touched on the trigeminal system as well, examining the connection between the CB1 gene (called CNR1) and people who reported migraines.
Cannabis Law Report
JUNE 11, 2019
While marijuana oil for sleep had been recommended, Hollyer had experienced some side effects after only a couple of months of use. While there is anecdotal evidence that CBD does have beneficial properties, I heard no evidence that that claim has been established through recognized clinical trials. ” 40. ” 42.
Cannabis Law Report
OCTOBER 29, 2019
“The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2009 July ; 205(1): 171–174.
Expert insights. Personalized for you.
130 
Let's personalize your content